Ahmad Aswad
Critical Care Medicine · Miami, FLNPI 1194956987
Payments from drug & device makers
$6,558,977in general payments, 2019–2025
Across 2,244 payments — averaging $2922.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$4.2M
- Akebia Therapeutics Inc$2.4M
- Astrazeneca UK Limited$2K
- Eisai Inc.$1K
- Alkermes, Inc.$21
General payments by program year
19
24
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1,206 | $4,188,047 |
| Akebia Therapeutics Inc | 1,020 | $2,367,846 |
| Astrazeneca UK Limited | 8 | $1,927 |
| Eisai Inc. | 9 | $1,136 |
| Alkermes, Inc. | 1 | $21 |
How this compares
$6,558,977 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.
Other critical care medicine in Miami
- Carlos VacaMiami$3M
- Michael CamposMiami$422K
- Alexandre AbreuMiami$179K
- Alexander FortMiami$102K
- Oveimar de la CruzMiami$89K
- Brian GarnetMiami$62K
- Daniel KettMiami$49K
- Raul FernandezMiami$20K
- Jeffrey LevyHollywood$19M
- George DuvallVero Beach$6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.